Genome-based vaccine development: A short cut for the future

Human Vaccines

Volumn 4, Issue 3, 2008, Pages 184-188

  Moriel, Danilo Gomes ^a   Scarselli, Maria ^a   Serino, Laura ^a   Mora, Marirosa ^a   Rappuoli, Rino ^a   Masignani, Vega ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Bioinformatics; Comparative genome analysis; Conventional vaccinology; Infectious diseases; Pan genome; Reverse vaccinology; Subtractive genome analysis; Vaccines

Indexed keywords

ANTHRAX VACCINE; BACTERIAL VACCINE; BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; PLAGUE VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; TETANUS TOXOID; TYPHOID VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE; BACTERIAL ANTIGEN;

BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL INFECTION; FUTUROLOGY; HOST PARASITE INTERACTION; HUMAN; NEISSERIA MENINGITIDIS; NONHUMAN; REVIEW; STREPTOCOCCUS AGALACTIAE; BACTERIAL INFECTIONS; GENETICS; IMMUNOLOGY;

ANTIGENS, BACTERIAL; BACTERIAL INFECTIONS; BACTERIAL VACCINES; GENOME, BACTERIAL; HUMANS; NEISSERIA MENINGITIDIS, SEROGROUP B; STREPTOCOCCUS AGALACTIAE;

EID: 48249129970     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.4.3.6313     Document Type: Review

References (22)

1. Fraser CM, Rappuoli R. Application of microbial genomic science to advanced therapeutics. Annu Rev Med 2005; 56:459-74.
2. FDA. Vaccines licensed for immunization and distribution in the USA. http://www.fda. gov/cber/vaccine/licvacc.htm. Accessed in 08/13/2007.
3. André FE. Vaccinology: past achievements, present roadblocks and future promises. Vaccine 2003; 21:593-5.
4. Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 2007; 6:404-14.
5. Rappuoli R. Reverse Vaccinology. Curr Opin Microbiol 2000; 3:445-50.
6. Plotkin SA. Vaccines: past, present and future. Nat Med 2005; 11:S5-11.
7. Pizza M, Scarlato V, Masignani V et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287:1816-20.
8. Mota M, Veggi D, Santini L et al. Reverse vaccinology. Drug Discov Today 2003; 8:459-64.
9. Tettelin H, Masignani V, Cieslewicz MJ et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci USA 2002; 99:12391-6.
10. Maione D, Margarit I, Rinaudo CD et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 2005; 309:148-50.
11. Wizemann TM, Heinrichs JH, Adamou JE et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 2001; 69:1593-8.
12. Ariel N, Zvi A, Grosfeld H et al. Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun 2002; 70:6817-27.
13. Montigiani S, Falugi F, Scarselli M et al. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun 2002; 70:368-79.
14. Ross BC, Czajkowski L, Hocking D et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine 2001; 19: 4135-42.
15. Tettelin H, Medini D, Donati C et al. Towards a universal group B Streptococcus vaccine using multistrain genome analysis. Expert Rev Vaccines 2006; 5:687-94.
16. Medini D, Donati C, Tettelin H et al. The microbial pan-genome. Curr Opin Genet Dev 2005; 15:589-94.
17. Mora M, Donati C, Medini D et al. Microbial genomes and vaccine design: refinements to the classical riverse vaccinology approach. Curr Opin in Microbiol 2006; 9:532-6.
18. Alekshun MN, Levy SB. Commensal upon us. Biochem Pharmacol 2006; 71:893-900.
19. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7:688-93.
20. Dagan R. The potential effect of widespread use of pneumococcal conjugate vaccines on the practice of pediatric otoryngology: the case of acute otitis media. Curr Opin Otoryngol Head Neck Surg 2004; 12:488-94.
21. Satola SW, Schirmer PL, Farley MM. Genetic analysis of the capsule locus of Haemophilus influenzae serotype f. Infect Immun 2003; 71:7202-7.
22. NCBI Microbial Genomes. http://www.ncbi.nlm.nih.gov/genomes/MICROBES/ microbial_taxtree.html. Accessed in 05/24/2008.